Results 311 to 320 of about 114,436 (357)
Some of the next articles are maybe not open access.
Stability of Lipid Excipients in Solid Lipid Nanoparticles
ChemInform, 2007AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
openaire +2 more sources
Current Drug Delivery, 2008
The first generation of solid lipid carrier systems in nanometer range, Solid Lipid Nanoparticles (SLN), was introduced as an alternative to liposomes. SLN are aqueous colloidal dispersions, the matrix of which comprises of solid biodegradable lipids.
S S, Shidhaye +4 more
openaire +2 more sources
The first generation of solid lipid carrier systems in nanometer range, Solid Lipid Nanoparticles (SLN), was introduced as an alternative to liposomes. SLN are aqueous colloidal dispersions, the matrix of which comprises of solid biodegradable lipids.
S S, Shidhaye +4 more
openaire +2 more sources
Solid Lipid Nanoparticles (SLN™)
2013Solid lipid nanoparticles (SLN™) are a new generation of drug delivery systems being exploited for several drugs since the nineties. These particles can be composed of different types of solid lipids, such as glycerides, waxes, and fatty acids, and stabilized by a wide range of surfactants.
Eliana B. Souto +2 more
openaire +1 more source
Current Drug Metabolism, 2020
Background: Solid Lipid Nanoparticles (SLNs) possess unique in vivo features such as high resistivity, bioavailability, and habitation at the target site. Coating nanoparticles with polymers such as chitosan greatly affects their pharmacokinetic behavior, stability, tissue uptake, and controlled drug delivery.
Nasrin Abbasi Gharibkandi +3 more
openaire +2 more sources
Background: Solid Lipid Nanoparticles (SLNs) possess unique in vivo features such as high resistivity, bioavailability, and habitation at the target site. Coating nanoparticles with polymers such as chitosan greatly affects their pharmacokinetic behavior, stability, tissue uptake, and controlled drug delivery.
Nasrin Abbasi Gharibkandi +3 more
openaire +2 more sources
Thymopentin in solid lipid nanoparticles
International Journal of Pharmaceutics, 1996Abstract The pentapeptide thymopentin was englobed in solid lipid nanoparticles prepared from warm microemulsions following two different methods: from O/W microemulsion by forming the more lipophilic ion-pair with hexadecylphosphate, and from W/O/W microemulsion by dissolving the pentapeptide in the aqueous internal phase.
Silvia Morel +3 more
openaire +1 more source
Oral solid lipid nanoparticle-based antitubercular chemotherapy
Tuberculosis, 2005The present study was planned to evaluate the chemotherapeutic potential of oral solid lipid nanoparticles (SLNs) incorporating rifampicin, isoniazid and pyrazinamide against experimental tuberculosis. The SLNs were prepared by the "emulsion solvent diffusion" technique with an encapsulation efficiency of 51+/-5% for rifampicin, 45+/-4% for isoniazid ...
Rajesh, Pandey +2 more
openaire +2 more sources
Solid lipid nanoparticles Production, characterization and applications
Advanced Drug Delivery Reviews, 2001Solid lipid nanoparticles (SLN) have attracted increasing attention during recent years. This paper presents an overview about the selection of the ingredients, different ways of SLN production and SLN applications. Aspects of SLN stability and possibilities of SLN stabilization by lyophilization and spray drying are discussed.
W, Mehnert, K, Mäder
openaire +2 more sources
Solid lipid nanoparticles for parenteral drug delivery
Advanced Drug Delivery Reviews, 2004This review describes the use of nanoparticles based on solid lipids for the parenteral application of drugs. Firstly, different types of nanoparticles based on solid lipids such as "solid lipid nanoparticles" (SLN), "nanostructured lipid carriers" (NLC) and "lipid drug conjugate" (LDC) nanoparticles are introduced and structural differences are ...
Wissing, S.A. +2 more
openaire +3 more sources